Benjamin Edwards’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
Other funds holding NVO
Benjamin Edwards's NVO Position: Q3 2026 in Review
Benjamin Edwards increased its Novo Nordisk (NVO) stake by 1.8% in Q3 2026, buying an estimated $38.7K and bringing the position to 46,598 shares worth $1.77M. The position accounts for 0.02% of the portfolio, ranked #613.
Benjamin Edwards first reported a position in NVO in Q4 2021 and has held it in 20 quarters since. The position peaked at $3.06M in Q3 2024. 1,061 funds tracked by Wall St. Rank hold NVO as of Q3 2026.
- Benjamin Edwards held 46,598 shares of Novo Nordisk worth $1.77M as of Q3 2026.
- Benjamin Edwards bought 840 Novo Nordisk shares in Q3 2026, an estimated $38.7K.
- Novo Nordisk made up 0.02% of Benjamin Edwards's portfolio in Q3 2026, its #613 holding.
- Benjamin Edwards first reported a position in Novo Nordisk in Q4 2021 and has held it in 20 quarters since.
- Benjamin Edwards's Novo Nordisk position peaked at $3.06M in Q3 2024.
- 1,061 funds tracked by Wall St. Rank held Novo Nordisk as of Q3 2026.
Based on Benjamin Edwards's 13F filing for Q3 2026, filed 12 Nov 2026.